|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/54 | (2017.01) |
| A61K 47/54 | (2017.08) | ||
| A61K 47/64 | (2017.01) | ||
| A61K 47/64 | (2017.08) | ||
| A61K 31/337 | (2013.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 31/4155 | (2013.01) | ||
| A61K 31/4155 | (2006.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61K 31/4375 | (2013.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/69 | (2006.01) | ||
| A61K 31/69 | (2013.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 31/704 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3154594 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15807049.0 |
| Date of filing the European patent application | 2015-06-15 | |
| (97) | Date of publication of the European application | 2017-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/035798 |
| Date | 2015-06-15 |
| (87) | Number | WO 2015/192123 |
| Date | 2015-12-17 |
| (30) | Number | Date | Country code |
| 201462011989 P | 2014-06-13 | US | |
| 201462051033 P | 2014-09-16 | US |
| (72) |
BACHOVCHIN, William, W. , US
LAI, Hung-sen , US
SANFORD, David, G. , US
POPLAWSKI, Sarah, E. , US
WU, Wengen , US
|
| (73) |
Bach Biosciences, LLC ,
31 Echo Landing, Moultonborough, NH 03254,
US
|
| (54) | FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO |
| FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO |